Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial

Composite cognitive scores have been developed as primary outcome measures for preclinical/prevention trials for Alzheimer’s disease (AD), mainly using observational data and with little consideration of clinical relevance.

from Dementia Big http://ift.tt/29xX9bw via alcoholic dementia

http://ift.tt/29EXYnP